KR840003641A - 피라졸로옥사진, 피라졸로티아진 및 피라졸로퀴놀린의 제조방법 - Google Patents

피라졸로옥사진, 피라졸로티아진 및 피라졸로퀴놀린의 제조방법 Download PDF

Info

Publication number
KR840003641A
KR840003641A KR1019830000448A KR830000448A KR840003641A KR 840003641 A KR840003641 A KR 840003641A KR 1019830000448 A KR1019830000448 A KR 1019830000448A KR 830000448 A KR830000448 A KR 830000448A KR 840003641 A KR840003641 A KR 840003641A
Authority
KR
South Korea
Prior art keywords
carbon atoms
aralkyl
alkyl
aryl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019830000448A
Other languages
English (en)
Korean (ko)
Inventor
마딘 마타르 (외 5)
Original Assignee
귄터 슈마허, 에리히 대브리츠
바이엘 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 귄터 슈마허, 에리히 대브리츠, 바이엘 아크티엔 게젤샤프트 filed Critical 귄터 슈마허, 에리히 대브리츠
Publication of KR840003641A publication Critical patent/KR840003641A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1019830000448A 1982-02-06 1983-02-05 피라졸로옥사진, 피라졸로티아진 및 피라졸로퀴놀린의 제조방법 Withdrawn KR840003641A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823204126 DE3204126A1 (de) 1982-02-06 1982-02-06 Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DEP3204126.8 1982-02-06

Publications (1)

Publication Number Publication Date
KR840003641A true KR840003641A (ko) 1984-09-15

Family

ID=6154989

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830000448A Withdrawn KR840003641A (ko) 1982-02-06 1983-02-05 피라졸로옥사진, 피라졸로티아진 및 피라졸로퀴놀린의 제조방법

Country Status (16)

Country Link
US (1) US4552874A (enExample)
EP (1) EP0085881A3 (enExample)
JP (1) JPS58146583A (enExample)
KR (1) KR840003641A (enExample)
AU (1) AU1112583A (enExample)
DE (1) DE3204126A1 (enExample)
DK (1) DK49283A (enExample)
ES (1) ES519559A0 (enExample)
FI (1) FI830378A7 (enExample)
GR (1) GR77960B (enExample)
HU (1) HU190063B (enExample)
IE (1) IE830227L (enExample)
IL (1) IL67826A0 (enExample)
NO (1) NO830236L (enExample)
PT (1) PT76147A (enExample)
ZA (1) ZA83743B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO834401L (no) * 1982-12-14 1984-06-15 Troponwerke Gmbh & Co Kg Pyrazolo(4.3-b)(1.4)oxasiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
US4634766A (en) * 1983-10-31 1987-01-06 Merck Frosst Canada, Inc. 1,4-diaza-phenothiazines
US4749699A (en) * 1983-10-31 1988-06-07 Merck Frosst Canada, Inc. 5-lipoxygenease inhibitors
ES8602818A1 (es) * 1983-10-31 1985-12-01 Merck Frosst Canada Inc Una composicion farmaceutica
US5756747A (en) * 1989-02-27 1998-05-26 Riker Laboratories, Inc. 1H-imidazo 4,5-c!quinolin-4-amines
US5037986A (en) * 1989-03-23 1991-08-06 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5116837A (en) * 1990-12-21 1992-05-26 Ortho Pharmaceutical Corporation 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4122035A1 (de) * 1991-07-03 1993-01-07 Henkel Kgaa Die verwendung von 1,9-dihydro-pyrazolo(4,3-b) (1,4)-benzoxazinen als kuppler fuer oxidationsfaerbemittel
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US6008218A (en) * 1995-12-08 1999-12-28 Ube Industries, Ltd. N-phenyl carbamate compounds, process for producing the same, and agricultural or horticultural bactericides
AR045261A1 (es) 2003-08-12 2005-10-19 3M Innovative Properties Co Compuestos que contienen imidazo quinolina o imidazo piridina sustituidos; composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos inmunomoduladores
ES2406730T3 (es) 2003-08-27 2013-06-07 3M Innovative Properties Company Imidazoquinolinas sustituidas con ariloxi y arilalquilenoxi
AU2004270201A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AR046046A1 (es) 2003-10-03 2005-11-23 3M Innovative Properties Co Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
US7897767B2 (en) 2003-11-14 2011-03-01 3M Innovative Properties Company Oxime substituted imidazoquinolines
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
MXPA06005910A (es) 2003-11-25 2006-08-23 3M Innovative Properties Co Sistemas de anillo imidazo sustituido y metodos.
EP1701955A1 (en) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
CA2559863A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
ES2392648T3 (es) 2004-12-30 2012-12-12 3M Innovative Properties Company Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
CA2597587A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
JP2008538550A (ja) 2005-04-01 2008-10-30 コーリー ファーマシューティカル グループ，インコーポレイテッド ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての１−置換ピラゾロ（３，４−ｃ）環状化合物
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
AU2008261884A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline derivatives
AU2008261803A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazolonaphthyridine derivatives
AU2008261888A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
ZA83743B (en) 1983-11-30
HU190063B (en) 1986-08-28
EP0085881A2 (de) 1983-08-17
DK49283A (da) 1983-08-07
PT76147A (en) 1983-02-01
GR77960B (enExample) 1984-09-25
US4552874A (en) 1985-11-12
ES8402591A1 (es) 1984-02-01
NO830236L (no) 1983-08-08
DE3204126A1 (de) 1983-08-11
FI830378L (fi) 1983-08-07
AU1112583A (en) 1983-08-11
JPS58146583A (ja) 1983-09-01
ES519559A0 (es) 1984-02-01
IL67826A0 (en) 1983-06-15
FI830378A0 (fi) 1983-02-03
DK49283D0 (da) 1983-02-04
FI830378A7 (fi) 1983-08-07
IE830227L (en) 1983-08-06
EP0085881A3 (de) 1984-03-07

Similar Documents

Publication Publication Date Title
KR840003641A (ko) 피라졸로옥사진, 피라졸로티아진 및 피라졸로퀴놀린의 제조방법
KR850003890A (ko) 1H-이미다조[4,5c]-퀴놀린-4-아민의 제조방법
ES2052696T5 (es) Fungicidas.
ES2056962T3 (es) Un procedimiento para la preparacion de nuevos derivados de camptotecina.
KR850001171A (ko) 퀴놀린 화합물의 제조방법
KR850007254A (ko) 니트로메틸렌 유도체의 제조방법
KR830009050A (ko) 항종양 퀴나졸린 화합물의 제조방법
KR840006475A (ko) 나프탈렌 유도체의 제조방법
ES466532A1 (es) Procedimiento para la obtencion de n-aridiazaciclos oxigena-dos.
KR840005464A (ko) 포스포리피드 유도체의 제조방법
KR840006482A (ko) 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법
ES458557A1 (es) Un procedimiento de preparacion de derivados de quinazolina.
ES342604A1 (es) Procedimiento para la obtencion de composiciones de fluidosfuncionales capaces de inhibir y controlar los danos causa- dos por la corrosion de elementos mecanicos en contacto con dichas composiciones.
ES465518A1 (es) Procedimiento para la obtencion de dehidrooligopeptidos.
KR840007006A (ko) 피라졸로[4,3-b] [1,4] 옥사진의 제조방법
KR840004065A (ko) 2-시아노-2-프로페노산 및 그 유도체의 제조방법
GB1197602A (en) Aminocycloalkylhydroquinone Derivatives
ES2039360T3 (es) Tetrahidro-beta-carbolinas, procedimiento para su preparacion y su utilizacion como medicamentos.
EP0127196A3 (en) Antihypertensive lactams
KR840008025A (ko) 5-이미노-1,2-디티올-온 화합물 및 그의 제법
GB1157642A (en) 3-Hydrazino-6-Amino-Pyridazines
JPS577459A (en) Novel phenylcarbamate derivative and analgesic containing the same
ES8603188A1 (es) Un procedimiento para la preparacion de compuestos de b -lactama
IE811860L (en) Polyazaheterocyclic compounds
EP0386258A4 (en) Tetrahydropyridine derivatives

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19830205

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid